Erik Wallström

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

Maria K. Storch, Andreas Stefferl, Uschi Brehm et al. · Brain Pathology · 1998 · 522 citations · Full text

Life Sciences, Neuroscience, Pathology +17

Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

Frida Lundmark, Kristina Duvefelt, Ellen Iacobaeus et al. · Nature Genetics · 2007 · 480 citations

Life Sciences, Immunology, Neurology +14

The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate

P Gergely, Barbara Nuesslein‐Hildesheim, Danilo Guerini et al. · British Journal of Pharmacology · 2012 · 304 citations · Full text

Life Sciences, Immunology, Pharmacology +15

MHC haplotype-dependent regulation of MOG-induced EAE in rats.

Robert Weissert, Erik Wallström, Maria K. Storch et al. · Journal of Clinical Investigation · 1998 · 255 citations · Full text

Life Sciences, Immunology, Neuroscience +17